GlassScriptPhysician profile
James D Mckay
NPI 1205840436
$4,685.03
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,310 · 2020: $899 · 2021: $1,476.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $720.89 | 2019-2021 | |
| Abbvie INC. | $715.57 | 2019-2021 | |
| Mallinckrodt Hospital Products INC. | $439.96 | 2020-2021 | |
| Lilly USA, LLC | $379.72 | 2019-2021 | |
| Genentech USA, INC. | $369.64 | 2019-2021 | |
| Ucb, INC. | $309.38 | 2019-2021 | |
| Janssen Biotech, INC. | $289.29 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $283.69 | 2019-2021 | |
| Mallinckrodt Enterprises LLC | $263.05 | 2019 | |
| Glaxosmithkline, LLC. | $250.13 | 2019-2021 | |
| Pfizer INC. | $181.95 | 2019-2021 | |
| Radius Health, INC. | $136.63 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $122.66 | 2019 | |
| Celgene Corporation | $89.42 | 2019 | |
| Aurinia Pharma U.S., INC. | $75.87 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $22.22 | 2019-2020 | |
| Medtronic USA, INC. | $18.42 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $11.68 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $4.86 | 2021 |
3 companies reported research payments only; those appear in the research section below.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Mckay listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
The CSV has this whole record: totals, yearly figures, every listed company, payment types, and product associations.
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.